|
Website:
http://www.impath.com
Phone: +1 212 698-0300 |
Address:
521 West 57th Street
NewYork, NEW YORK 10019 |
Company Description
Impath Inc. The principal activity of the Group is to establish a specialized facility to provide diagnostic and prognostic information to hospitals, medical centers, clinical laboratories and physicians specializing in cancer. The Group also provides monoclonal antibody and molecular probe characterization services, global medical research network and licenses tumor registry software. The Group conducts this analysis by utilizing immunohistochemistry, molecular pathology, micrometastases detection and serum analysis technologies. On 18-Jan-2002 the Group acquired Tamtron Corporation. IMPATH Physician Services accounted for 81% of 2002 revenues; IMPATH Predictive Oncology, 12% and IMPATH Information services, 7%. IMPATH Physician Services accounted for 81% of 2002 revs; IMPATH Predictive Oncology, 12% and IMPATH Information services, 7%
Key People
| Chairman & Chief Executive | Carter H. Eckert |
| Senior Vice President & Chief Financial Officer | James V. Agnello |
| Secretary & General Counsel | Richard C. Rosenzweig |
Related Business Topics
0-9 |
A |
B |
C |
D |
E |
F |
G |
H |
I |
J |
K |
L |
M |
N |
O |
P |
Q |
R |
S |
T |
U |
V |
W |
X |
Y |
Z
I
